Kooperativer Bibliotheksverbund

UID:

Umfang: XI, 293 p. , online resource.

Ausgabe: 1st ed. 2024.

ISBN: 9783031588037

Inhalt: This book is a compendium of the worldwide ocular stem cell, gene therapy, pharmaceutical, and other miscellaneous studies treating Age-Related Macular Degeneration registered with Clinicaltrials.gov. Clinicaltrials.gov is the largest website listing of registered clinical research studies in the world. The study and the clinical trial numbers are provided in order to make it easier for the reader to obtain further information. The book also includes an introduction on Age-Related Macular Degeneration as well as analysis of the clinical studies. Clinical Trials in Age-Related Macular Degeneration Treatment is a valuable resource for ophthalmologists, optometrists, other physicians, and researchers.

Anmerkung: Part 1: Introduction -- Chapter 1. Introduction to Age-Related Macular Degeneration -- Chapter 2. Tables -- Part 2: Stem Cell Studies -- Chapter 3. United States -- Chapter 4. Caribbean -- Chapter 5. China -- Chapter 6. Great Britain -- Part 3: Gene Therapy Trials -- Chapter 7. United States -- Chapter 8. Canada -- Chapter 9. China -- Part 4: Other Trials -- Chapter 10. United States -- Chapter 11. Australia -- Chapter 12. Austria -- Chapter 13. China -- Chapter 14. Italy -- Chapter 15. Korea -- Chapter 15. Norway -- Chapter 16. South America -- Chapter 17. Thailand.

In: Springer Nature eBook

Weitere Ausg.: Printed edition: ISBN 9783031588020

Weitere Ausg.: Printed edition: ISBN 9783031588044

Weitere Ausg.: Printed edition: ISBN 9783031588051

Sprache: Englisch

DOI: 10.1007/978-3-031-58803-7

URL: https://doi.org/10.1007/978-3-031-58803-7

URL: Volltext  (URL des Erstveröffentlichers)

URL: Volltext  (URL des Erstveröffentlichers)

URL: Volltext  (URL des Erstveröffentlichers)

UID:

Umfang: 1 online resource (300 pages)

Ausgabe: First edition.

ISBN: 9783031588037

Anmerkung: Includes index. , Intro -- Preface -- Contents -- Chapter 1: Introduction to Age-Related Macular Degeneration -- Further Reading -- Chapter 2: Tables -- Chapter 3: Stem Cell Studies -- United States -- Recruiting -- Safety and Tolerability of RPE Stem Cell-derived RPE (RPESC-RPE) Transplantation in Patients with Dry Age-Related Macular Degeneration (AMD) -- ClinicalTrials.gov ID NCT04627428 -- United States -- Recruiting -- Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated with Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT04339764 -- United States -- Recruiting -- Stem Cell Ophthalmology Treatment Study II (SCOTS2) -- ClinicalTrials.gov ID NCT03011541 -- United States -- Recruiting -- A Study of the Safety and Tolerability of ASP7317 in Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT03178149 -- Caribbean -- Recruiting -- Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases -- ClinicalTrials.gov ID NCT05147701 -- China -- Not Yet Recruiting -- Preparation of Patient Autologous-Induced Pluripotent Stem Cell-Derived Retinal Cells for AMD -- ClinicalTrials.gov ID NCT05991986 -- China -- Recruiting -- Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration -- ClinicalTrials.gov ID NCT05445063 -- Great Britain -- Recruiting -- A Study of Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT01691261 -- Great Britain -- Not Yet Recruiting -- Retinal Pigment Epithelium Safety Study for Patients in B4711001 -- ClinicalTrials.gov ID NCT03102138 -- Chapter 4: Gene Therapy Trials -- United States. , Not Yet Recruiting -- Phase I/II Study of SKG0106 Intraocular Solution in Patients with Neovascular Age-Related Macular Degeneration (nAMD) -- ClinicalTrials.gov ID NCT05986864 -- United States -- Recruiting -- 4D-150 in Patients with Neovascular (Wet) Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05197270 -- United States -- Recruiting -- RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants with Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE) -- ClinicalTrials.gov ID NCT04514653 -- United States -- Recruiting -- Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients with Neovascular Age-Related Macular Degeneration [LUNA] -- ClinicalTrials.gov ID NCT05536973 -- United States -- Recruiting -- A Study of EXG102-031 in Patients with wAMD (Everest) -- ClinicalTrials.gov ID NCT05903794 -- United States -- Recruiting -- Pivotal 2 Study of RGX-314 Gene Therapy in Participants with nAMD (ASCENT) -- ClinicalTrials.gov ID NCT05407636 -- United States -- Recruiting -- Pivotal 1 Study of RGX-314 Gene Therapy in Participants with nAMD (ATMOSPHERE) -- ClinicalTrials.gov ID NCT04704921 -- Canada -- Recruiting -- NG101 AAV Gene Therapy in Subjects with Wet Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05984927 -- China -- Recruiting -- Safety and Tolerability of KH631 Gene Therapy in Participants with Neovascular Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05657301 -- China -- Recruiting -- Safety and Tolerability of KH631 Gene Therapy in Subjects with Neovascular Age-Related Macular Degeneration (nAMD) -- ClinicalTrials.gov ID NCT05672121 -- China -- Not Yet Recruiting -- Gene Therapy for Wet AMD -- ClinicalTrials.gov ID NCT05611424 -- China -- Recruiting -- CRISPR/Cas13-Mediated RNA Targeting Therapy for the Treatment of nAMD Investigator-Initiated Trial (SIGHT-I). , ClinicalTrials.gov ID NCT06031727 -- China -- Recruiting -- VEGFA-Targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases -- ClinicalTrials.gov ID NCT05099094 -- China -- Not Yet Recruiting -- An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients with nAMD -- ClinicalTrials.gov ID NCT06022744 -- Chapter 5: Other Trials -- United States -- Recruiting -- Microcurrent Stimulation Therapy for Nonexudative Age-Related Macular Degeneration (i-SIGHT) -- ClinicalTrials.gov ID NCT05447650 -- United States -- Recruiting -- A Masked, Placebo-Controlled Study to Assess Iptacopan in Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05230537 -- United States -- Recruiting -- Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants with Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD) -- ClinicalTrials.gov ID NCT05893537 -- United States -- Recruiting -- Evaluation of OLX10212 in Patients with Neovascular Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05643118 -- United States -- Recruiting -- Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration (ODYSSEY) -- ClinicalTrials.gov ID NCT05891548 -- United States -- Recruiting -- Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients with Neovascular Age-Related Macular Degeneration [LUNA] -- ClinicalTrials.gov ID NCT05536973 -- United States -- Recruiting -- Study of Zifibancimig in Participants with Neovascular Age-Related Macular Degeneration (BURGUNDY) -- ClinicalTrials.gov ID NCT04567303 -- United States -- Not Yet Recruiting -- Non-invasive Ultrasound Retinal Stimulation for Vision Restoration -- ClinicalTrials.gov ID NCT05914233 -- United States -- Recruiting. , A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants with Geographic Atrophy Secondary to Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05626114 -- United States -- Recruiting -- Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy (PHOENIX) -- ClinicalTrials.gov ID NCT05949593 -- Australia -- Not Yet Recruiting -- Safety of BBC1501 Intravitreal Injection in Patients with Neovascular Age-Related Macular Degeneration (nAMD) -- ClinicalTrials.gov ID NCT05803785 -- Australia -- Recruiting -- Subthreshold Laser Treatment in Intermediate Age-Related Macular Degeneration with Nascent Geographic Atrophy Study (LIANA) -- ClinicalTrials.gov ID NCT05200624 -- Austria -- Recruiting -- Faricimab for High-Frequent Aflibercept Treated Neovascular Age-Related Macular Degeneration (FAN) -- ClinicalTrials.gov ID NCT05941715 -- Austria -- Recruiting -- Therapy of Age-Related Macular Degeneration (MET) -- ClinicalTrials.gov ID NCT05222997 -- China -- Not Yet Recruiting -- A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-Related Macular Degeneration (wAMD) -- ClinicalTrials.gov ID NCT04572698 -- China -- Recruiting -- Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with wAMD -- ClinicalTrials.gov ID NCT05003245 -- China -- Recruiting -- A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with wAMD -- ClinicalTrials.gov ID NCT04740671 -- China -- Recruiting -- Treatment of Recalcitrant Neovascular AMD Using Brolocizumab with Immediate T& -- E -- ClinicalTrials.gov ID NCT05710471 -- China -- Recruiting -- Study of IBI333 in Subjects with Neovascular Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05639530 -- China -- Recruiting. , QA108 Phase II Study in Subjects with Intermediate Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05562219 -- Italy -- Recruiting -- Photobiomodulation in Dry Age-Related Macular Degeneration (DRUSEN) -- ClinicalTrials.gov ID NCT06046118 -- Korea -- Recruiting -- Study of Application of Transcutaneous Pulsed Electrical Stimulation Around Eye in Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05259371 -- Norway -- Not Yet Recruiting -- Photobiomodulation for Dry Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05507840 -- South America -- Recruiting -- OcuDyne System in the Treatment of AMD -- ClinicalTrials.gov ID NCT05091476 -- Thailand -- Recruiting -- A Study to Investigate the Effect on Central Macular Thickness of Treatment with MG-O-1002 Eye Drops in Participants Aged over 45 with Neovascular Age-Related Macular Degeneration (nAMD) -- ClinicalTrials.gov ID NCT05390840 -- Index.

Weitere Ausg.: Print version: Weiss, Jeffrey N. Clinical Trials in Age-Related Macular Degeneration Treatment Cham : Springer International Publishing AG,c2024 ISBN 9783031588020

Sprache: Englisch